Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey

AIM: We examined eligibility and preventable cardiovascular disease events in US adults with diabetes mellitus from the Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME). METHODS: We identified adults with diabetes mellitus eligible for EMPA-REG...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Nathan D, Fan, Wenjun, Pak, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510356/
https://www.ncbi.nlm.nih.gov/pubmed/32722930
http://dx.doi.org/10.1177/1479164120945674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510356/
https://www.ncbi.nlm.nih.gov/pubmed/32722930
http://dx.doi.org/10.1177/1479164120945674

Ejemplares similares